Catalyst
Slingshot members are tracking this event:
Takeda Acquires U.S. Biologics Manufacturing Facility from Baxalta for the manufacture of Entyvio (vedolizumab)
- Source Link:
- http://www.takeda.com/news/2016/20160106_7262.html
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
TKPYY |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 06, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Acquisition, Manufacturing, Entyvio, Vedolizumab